Home / News / Prnews / I-Mab to Release Q3 2024 Financial Results on November 14, 2024

Prnews

I-Mab to Release Q3 2024 Financial Results on November 14, 2024

Cision | Thu, Oct 31 2024 10:00 PM AEDT

stock

Image Source:Kalkine Media

ROCKVILLE, Md., Oct. 31, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that it plans to release financial results for the third quarter ended September 30, 2024, on Thursday, November 14, 2024, pre-market Eastern Time.

The Company will not host a conference call to discuss its third quarter 2024 financial results. The Company intends to host an investor update call in conjunction with its 2024 full-year financial results to discuss its clinical pipeline, corporate strategy, and objectives. Information about financial results, conference calls, webcasts, and other information is posted on the Company's website.

About I-Mab

I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer.

I-Mab has established operations in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit https://www.i-mabbiopharma.com and follow us on LinkedIn and X.

I-Mab Investor & Media Contacts
Tyler Ehler
Senior Director, Investor Relations
[email protected]

More For You

PRNews

"Pinkfong & Hogi Mini Movie: The Tricky Three Cars" to Premiere Globally on Netflix

Cision | Fri, Nov 01 2024 12:05 AM AEDT

stock

-  Pinkfong's hit series "Pinkfong Wonderstar" expands ...

PRNews

Stamus Networks Partners with Specialist Distributor Titan Data Solutions

Cision | Fri, Nov 01 2024 12:01 AM AEDT

stock

Stamus Networks becomes the first network detection and respons...

PRNews

The One-Year Outcome of LuX-Valve Plus TRAVEL II Study was Officially Released at TCT 2024

Cision | Fri, Nov 01 2024 12:00 AM AEDT

stock

WASHINGTON, Oct. 31, 2024 /PRNewswire/ -- Jenscare Scientific Co., Ltd...